Financial report interval: 2025.12.31 - 2026.03.31
Preview: CSPC PHARMA(01093) predict that the Revenue is 7.465 B (-2.34%), Miss estimate;the EBIT is 1.334 B (-31.7%), Miss estimate;the EPS is 0.0871 (-38.11%), Miss estimate.